Keyword: Roche

News

EU Approves Roche’s Leukemia Drug

01.06.2016 - The European Commission has approved a subcutaneous formulation of Roche’s MabThera for chronic lymphocytic leukemia (CLL) which saves time and eases the treatment burden compared...

News

Medivation not Bending to Sanofi Pressure

09.05.2016 - Sanofi is turning up the heat on its acquisition target, US biopharmaceuticals producer Medivation, but the strategy doesn’t seem to be working. Last week, the French drugmaker...

News

Novartis Seen Mulling Roche Share Sale

26.04.2016 - Novartis is said to be planning to divest its nearly $14 billion stake in rival Swiss drugmaker Roche, accounting for about 6% of that company’s shares and more than 30% of its...

News

Lilly-backed Study Confirms Evacetrapib Fail

05.04.2016 - Results from the just-concluded studies of the Eli Lilly drug candidate evacetrapib by the Cleveland Clinic in Ohio, USA, have underscored other findings that industry watchers...

News

Blueprint and Roche in Cancer Immunotherapy Deal

17.03.2016 - US biotechnology company Blueprint Medicines is collaborating with Swiss drugs giant Roche on the discovery, development and commercialization of up to five cancer immunotherapies...

News

Breakthrough Drug Status for Roche and AstraZeneca

19.02.2016 - Major drug makers Roche and AstraZeneca have been granted breakthrough therapy designations (BTD) by the US Food and Drug Administration (FDA) for treatments in multiple sclerosis...

Chemistry & Life Sciences

DCAT Week ’16

03.02.2016 - A key upcoming industry event is DCAT Week, the flagship event of the Drug, Chemical & Associated Technologies Association (DCAT). DCAT Week brings together pharmaceutical and...

News

Global Data Sees Indian Generics Soaring

29.01.2016 - The value of the Indian pharmaceutical market is set to nearly quadruple over the next five years, soaring from $20 billion in 2015 to $55 billion by 2020, according to GlobalData...